Q1 2026 · 13F-HR
Sio Capital Management, LLCholdings as filed
Filed 2026-05-14 · accession 0001214659-26-006200
$697.3M
Reported value
76
Positions
2026-03-31
Period end
The Brief · Sio Capital Management, LLC · Q1 2026
AI · grounded in 13F
Sio Capital Management, LLC exited its position in The Cigna Group CI, reducing its exposure by $47.4M. The fund established new positions in Corcept Therapeutics Inc CORT for $27.2M, GSK PLC GSK for $21.3M, and Abbott Laboratories ABT for $19.2M. Additionally, the fund closed out holdings in Rhythm Pharmaceuticals Inc RYTM and Kenvue Inc KVUE.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 577933104 | MMS | MAXIMUS INC | $49.3M | 7.07% | 768,825 | Common | SOLE |
| 946784105 | WAY | WAYSTAR HLDG CORP | $39.6M | 5.68% | 1,642,236 | Common | SOLE |
| G4705A100 | ICLR | ICON PLC | $33.9M | 4.86% | 306,358 | Common | SOLE |
| 03073E105 | COR | CENCORA INC | $31.7M | 4.55% | 100,894 | Common | SOLE |
| 252828108 | DNTH | DIANTHUS THERAPEUTICS INC | $31.1M | 4.45% | 370,045 | Common | SOLE |
| 03675P102 | AVR | ANTERIS TECHNOLOGIES GLOBAL | $29.9M | 4.28% | 5,382,965 | Common | SOLE |
| 218352102 | CORT | CORCEPT THERAPEUTICS INC | $27.2M | 3.90% | 674,759 | Common | SOLE |
| G5509L101 | LIVN | LIVANOVA PLC | $26.8M | 3.84% | 421,615 | Common | SOLE |
| 90240B106 | TYRA | TYRA BIOSCIENCES INC | $23.2M | 3.33% | 605,439 | Common | SOLE |
| 15102K100 | CELC | CELCUITY INC | $22.1M | 3.17% | 193,843 | Common | SOLE |
| 37733W204 | GSK | GSK PLC | $21.3M | 3.05% | 385,879 | Common | SOLE |
| 00182C103 | ANIP | ANI PHARMACEUTICALS INC | $20.4M | 2.93% | 265,543 | Common | SOLE |
| 002824100 | ABT | ABBOTT LABORATORIES | $19.2M | 2.75% | 186,574 | Common | SOLE |
| 29082K105 | EMBC | EMBECTA CORP | $16.3M | 2.34% | 1,847,850 | Common | SOLE |
| 00370M103 | ABVX | ABIVAX SA | $15.1M | 2.17% | 135,800 | Common | SOLE |
| 92764N102 | VIR | VIR BIOTECHNOLOGY INC | $13.4M | 1.93% | 1,498,620 | Common | SOLE |
| 405024100 | HAE | HAEMONETICS CORP MASS | $12.4M | 1.78% | 220,672 | Common | SOLE |
| 829401108 | SION | SIONNA THERAPEUTICS INC | $11.8M | 1.69% | 294,340 | Common | SOLE |
| 80105N105 | SNY | SANOFI SA | $11.5M | 1.66% | 239,671 | Common | SOLE |
| 75383L102 | RAPP | RAPPORT THERAPEUTICS INC | $11.5M | 1.65% | 366,809 | Common | SOLE |
| 879369106 | TFX | TELEFLEX INCORPORATED | $11.3M | 1.63% | 94,800 | Common | SOLE |
| 09061G101 | BMRN | BIOMARIN PHARMACEUTICAL INC | $11.0M | 1.57% | 194,226 | Common | SOLE |
| 227483104 | CCRN | CROSS CTRY HEALTHCARE INC | $10.3M | 1.48% | 1,098,393 | Common | SOLE |
| 74365U107 | TARA | PROTARA THERAPEUTICS INC | $10.3M | 1.47% | 1,969,839 | Common | SOLE |
| 86366E106 | GPCR | STRUCTURE THERAPEUTICS INC | $10.1M | 1.45% | 209,093 | Common | SOLE |
| G1110E107 | BHVN | BIOHAVEN LTD | $9.8M | 1.41% | 1,163,926 | Common | SOLE |
| 61023L207 | MNPR | MONOPAR THERAPEUTICS INC | $9.5M | 1.36% | 173,506 | Common | SOLE |
| 30233G209 | EYPT | EYEPOINT INC | $9.3M | 1.33% | 721,785 | Common | SOLE |
| 22663K107 | CRNX | CRINETICS PHARMACEUTICALS IN | $9.1M | 1.30% | 249,887 | Common | SOLE |
| 28036F105 | EWTX | EDGEWISE THERAPEUTICS INC | $8.5M | 1.22% | 268,986 | Common | SOLE |
| 20451W101 | CMPS | COMPASS PATHWAYS PLC | $8.3M | 1.19% | 1,506,525 | Common | SOLE |
| 67576A100 | OCUL | OCULAR THERAPEUTIX INC | $8.2M | 1.18% | 968,597 | Common | SOLE |
| 03843E104 | AQST | AQUESTIVE THERAPEUTICS INC | $8.0M | 1.14% | 1,922,887 | Common | SOLE |
| 75955J402 | RLMD | RELMADA THERAPEUTICS INC | $6.7M | 0.96% | 965,000 | Common | SOLE |
| 687604108 | ORKA | ORUKA THERAPEUTICS INC | $6.5M | 0.93% | 132,496 | Common | SOLE |
| 98937L105 | ZBIO | ZENAS BIOPHARMA INC | $6.5M | 0.93% | 331,730 | Common | SOLE |
| 10919W405 | DRUG | BRIGHT MINDS BIOSCIENCES INC | $6.3M | 0.90% | 86,083 | Common | SOLE |
| 219798105 | QDEL | QUIDELORTHO CORP | $5.9M | 0.85% | 359,011 | Common | SOLE |
| 98956P102 | ZBH | ZIMMER BIOMET HOLDINGS INC | $5.7M | 0.81% | 62,613 | Common | SOLE |
| 76029N106 | REPL | REPLIMUNE GROUP INC | $5.5M | 0.79% | 720,036 | Common | SOLE |
| 68622V106 | OGN | ORGANON & CO | $5.2M | 0.74% | 865,908 | Common | SOLE |
| 68277Q105 | OKUR | ONKURE THERAPEUTICS INC | $4.5M | 0.64% | 1,078,965 | Common | SOLE |
| 254604101 | IRON | DISC MEDICINE INC | $4.2M | 0.60% | 65,203 | Common | SOLE |
| 69353Y103 | PMVP | PMV PHARMACEUTICALS INC | $3.8M | 0.55% | 3,076,580 | Common | SOLE |
| 45257U108 | IMNM | IMMUNOME INC | $3.6M | 0.52% | 165,110 | Common | SOLE |
| 457985208 | IART | INTEGRA LIFESCIENCES HLDGS C | $3.6M | 0.52% | 383,140 | Common | SOLE |
| 805111101 | SVRA | SAVARA INC | $3.4M | 0.48% | 613,888 | Common | SOLE |
| 15135B101 | CNC | CENTENE CORP DEL | $3.3M | 0.47% | 100,000 | PUT | SOLE |
| N71542109 | PRQR | PROQR THERAPEUTICS N V | $3.2M | 0.45% | 1,954,715 | Common | SOLE |
| 82537J108 | SI | SHOULDER INNOVATIONS INC | $3.1M | 0.44% | 210,641 | Common | SOLE |
| 690469101 | OVID | OVID THERAPEUTICS INC | $2.8M | 0.40% | 1,252,381 | Common | SOLE |
| 501575104 | KYMR | KYMERA THERAPEUTICS INC | $2.7M | 0.39% | 32,235 | Common | SOLE |
| 01626L204 | ALGS | ALIGOS THERAPEUTICS INC | $2.4M | 0.35% | 327,237 | Common | SOLE |
| 21077P108 | CNTX | CONTEXT THERAPEUTICS INC | $2.4M | 0.34% | 917,922 | Common | SOLE |
| 037326105 | ANTX | AN2 THERAPEUTICS INC | $2.2M | 0.32% | 657,200 | Common | SOLE |
| 81751A108 | SER | SERINA THERAPEUTICS INC | $1.9M | 0.28% | 1,000,000 | Common | SOLE |
| 451033708 | IBIO | IBIO INC | $1.7M | 0.25% | 904,268 | Common | SOLE |
| 00534B100 | ADGM | ADAGIO MED HLDGS INC | $1.5M | 0.21% | 1,288,461 | Common | SOLE |
| 98422T209 | XLO | XILIO THERAPEUTICS INC | $1.3M | 0.18% | 152,464 | Common | SOLE |
| 107924102 | BBOT | BRIDGEBIO ONCOLOGY THERAPEUT | $1.2M | 0.17% | 130,628 | Common | SOLE |
| 44916K106 | HYPR | HYPERFINE INC | $1.1M | 0.15% | 1,000,000 | Common | SOLE |
| 81727U303 | SENS | SENSEONICS HLDGS INC | $771,121 | 0.11% | 115,784 | Common | SOLE |
| 344174107 | FHTX | FOGHORN THERAPEUTICS INC | $587,409 | 0.08% | 122,889 | Common | SOLE |
| 880881107 | 430 | TERNS PHARMACEUTICALS INC | $532,472 | 0.08% | 10,100 | Common | SOLE |
| 29251M106 | ENTA | ENANTA PHARMACEUTICALS INC | $505,200 | 0.07% | 40,000 | Common | SOLE |
| 872381108 | TELA | TELA BIO INC | $394,506 | 0.06% | 636,300 | Common | SOLE |
| 64130M209 | — | NEUROONE MED TECHNOLOGIES CO | $385,621 | 0.06% | 496,614 | Common | SOLE |
| 10170A100 | BOLD | BOUNDLESS BIO INC | $180,047 | 0.03% | 163,679 | Common | SOLE |
| B6S7WD106 | NYXH | NYXOAH S A | $148,450 | 0.02% | 50,839 | Common | SOLE |
| 60785L306 | MODD | MODULAR MED INC | $138,283 | 0.02% | 26,190 | Common | SOLE |
| 28657F103 | ELTX | ELICIO THERAPEUTICS INC | $125,073 | 0.02% | 11,700 | PUT | SOLE |
| 29479A108 | ERAS | ERASCA INC | $80,900 | 0.01% | 5,000 | Common | SOLE |
| 687793109 | OSCR | OSCAR HEALTH INC | $34,410 | 0.00% | 3,000 | PUT | SOLE |
| 77313F114 | RCKTW | ROCKET PHARMACEUTICALS INC | $7,020 | 0.00% | 400,000 | Common | SOLE |
| 44486Q111 | HUMAW | HUMACYTE INC | $4,572 | 0.00% | 49,998 | Common | SOLE |
| 829214105 | SLP | SIMULATIONS PLUS INC | $2,364 | 0.00% | 200 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.